The U.S. Centers for Disease Control and Prevention (CDC) has revised its guidance on COVID-19 vaccines for children, stating that vaccination for healthy individuals aged 6 months to 17 years should follow a “shared clinical decision-making” process. This means that shots are still available, but only if parents and doctors agree it's necessary based on individual circumstances.
The move marks a shift from earlier CDC guidance, which broadly recommended updated COVID-19 vaccines for everyone six months and older. The updated schedule, published Thursday, outlines that if parents want their child vaccinated, they may proceed based on a healthcare provider’s judgment and the family’s preference.
Health Secretary Robert F. Kennedy Jr., a known vaccine skeptic, claimed earlier in the week that COVID vaccines for healthy children and pregnant women had been removed from the CDC’s immunization schedule. However, a Department of Health and Human Services spokesperson said there is no contradiction, as the CDC’s updated guidance no longer promotes universal vaccination for healthy children but still allows it case-by-case.
Medical experts criticized Kennedy’s unilateral announcement, saying it bypassed the CDC’s usual advisory process. The Infectious Diseases Society of America warned the change may limit access and insurance coverage, especially for vulnerable children. They emphasized that COVID-19 can cause serious illness in children, including long COVID symptoms that may impact development.
According to CDC data, nearly 1,900 children under 18 have died from COVID-19 in the U.S. as of 2023. Vaccine makers Pfizer, Moderna, and Novavax have not commented on the development.
The FDA also recently announced it would require new clinical trials for annual COVID boosters in healthy individuals under 65, reinforcing a more limited use strategy moving forward.


Merck Nears Acquisition of Cidara Therapeutics at Significant Premium
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market
FDA Pilot Program Eases Rules for Nicotine Pouch Makers
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Pfizer Sues Novo Nordisk Over Alleged Tactics to Block Obesity Drug Competition
Trump Administration Tightens H-1B Visa Vetting With New Focus on Free Speech and Censorship
Afghan Suspect in Deadly Shooting of National Guard Members Faces First-Degree Murder Charge
Peru Moves to Declare State of Emergency at Chile Border as Migrant Tensions Rise
Trump Calls for Permanent Pause on Migration After National Guard Shooting Near White House
Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement
Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand
New Orleans Immigration Crackdown Sparks Fear as Federal Arrests Intensify
Trump Administration Plans Major Rollback of Biden-Era Fuel Economy Standards
USPS Expands Electric Vehicle Fleet as Nationwide Transition Accelerates
U.S. Experts to Reassess Newborn Hepatitis B Vaccination Guidelines Amid Growing Debate
National Guard Member Killed in White House-Area Shooting Sparks Terror Probe and Immigration Review 



